Blood glucose test strips: Options to reduce usage

CMAJ. Canadian Medical Association Journal

Volumn 182, Issue 1, 2010, Pages 35-38

  Gomes, Tara ^e   Juurlink, David N ^a,c,d,e   Shah, Baiju R ^a,c,d,e   Paterson, J Michael ^e,f,g   Mamdani, Muhammad M ^b,c,d,e  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ARTICLE; BLOOD GLUCOSE MONITORING; CALCULATION; CANADA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; PRESCRIPTION; RISK ASSESSMENT; SELF MONITORING; STRATIFICATION; TEST STRIP; BLOOD; ECONOMICS; HEALTH CARE COST; HEALTH INSURANCE; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

BLOOD GLUCOSE SELF-MONITORING; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEALTH EXPENDITURES; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MIDDLE AGED; ONTARIO;

EID: 77949400805     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.091017     Document Type: Article

References (20)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32:S1-201.
2. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care 2009;32(Suppl 1):S13-61.
3. National Prescribing Centre of the National Health Service. When and how should patients with diabetes mellitus test blood glucose? MeReC Bulletins 2002;13:1-4.
4. Karter AJ. Role of self-monitoring of blood glucose in glycemic control. Endocr Pract 2006;12(Suppl 1):110-7.
5. Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review. Diabetes Care 1997;20:1482-6.
6. Davidson MB, Castellanos M, Kain D, et al. The effect of self-monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005;118:422-5.
7. Farmer A, Wade A, Goyder E, et al. Impact of self-monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007;335:132.
8. Guerci B, Drouin P, Grange V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587-94.
9. O'Kane MJ, Bunting B, Copeland M, et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008;336:1174-7.
10. Kennedy L. Self-monitoring of blood glucose in type 2 diabetes: time for evidence of efficacy. Diabetes Care 2001;24:977-8.
11. Canadian Optimal Medication Prescribing and Utilization Service. Systematic review of use of blood glucose test strips for the management of diabetes mellitus. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2009. Available: www.cadth.ca/media/pdf/compus-Draft-BGTS-SR-report- of-clinical-outcome.pdf (accessed 2009 Oct 20).
12. Davis WA, Bruce DG, Davis TM. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007;50:510-5.
13. Canadian Optimal Medication Prescribing and Utilization Service. Optimal therapy recommendations for the prescribing and use of blood glucose test strips. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2009. Available: www.cadth.ca/index.php/en/compus/compus-publications/ publication/874 (accessed 2009 Oct. 20).
14. Ontario Ministry of Health and Long-Term Care. 2007/08 interim report card for the Ontario Drug Benefit program. Ottawa (ON); 2009. Available: www.health.gov.on.ca/en/public/publications/ministry-reports/odb-report08/ drug-rep08.aspx (accessed 2009 Oct 20).
15. Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-6.
16. Gomes T, Juurlink DN, Lipscombe LL, et al. Clinical and demographic characteristics of patients receiving different oral hypoglycemic agents. Pharmacoepidemiol Drug Saf 2009;18:756-60.
17. Levy AR, O'Brien BJ, Sellers C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003;10:67-71.
18. Canadian Optimal Medication Prescribing and Utilization Service. Current practice analysis of health care providers and patients on self-monitoring of blood glucose. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2009. Available: www.cadth.ca/media/pdf/compus-Current- Practice-Report-Vol-3-Issue-5.pdf (accessed 2009 Oct 20).
19. Sanyal C, Graham SD, Cooke C, et al. The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada. BMC Health Serv Res 2008:8:111.
20. Gomes T, Juurlink DN, Shah BR, et al. Blood glucose test strip costs and potential savings associated with reduced testing. ICES Investigative Report. Toronto (ON): Institute for Clinical Evaluative Sciences.